Safety and efficacy of recombinant human bone morphogenetic protein 2 on cranial defect closure in the pediatric population.
Safety and efficacy of recombinant human bone morphogenetic protein 2 on cranial defect closure in the pediatric population. J Craniofac Surg. 2013 May; 24(3):917-22.